Inventor
ROMERO PEDRO
CH13 patents
⚠️ This page may combine multiple inventors who share the name “ROMERO PEDRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
11 patentsUS6605711B1Aug 12, 2003
NY-ESO-1 peptide derivatives, and uses thereof
LUDWIG INST CANCER RES39 citations91
US6326200B1Dec 4, 2001
Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof
LUDWIG INST CANCER RES24 citations91
US6025470AFeb 15, 2000
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
LUDWIG INST CANCER RES26 citations91
US6417165B1Jul 9, 2002
NY-ESO-1-peptide derivatives, and uses thereof
LUDWIG INST CANCER RES37 citations89
US5827073AOct 27, 1998
Photoreactive peptide derivatives
LUDWIG INST CANCER RES17 citations74
US6384190B1May 7, 2002
Isolated decapeptides which bind to HLA molecules
LUDWIG INST CANCER RES5 citations72
US6368857B1Apr 9, 2002
Method for provoking proliferation of cytolytic T cells via the use of decapeptides which complex with HLA-A2 molecules
LUDWIG INST CANCER RES8 citations72
US6277956B1Aug 21, 2001
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
LUDWIG INST CANCER RES6 citations72
US6222012B1Apr 24, 2001
Isolated nonapeptides presented by HLA molecules, and uses thereof
LUDWIG INST CANCER RES10 citations71
US7713714B2May 11, 2010
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
LUDWIG INST CANCER RES0 citations51
US7344879B2Mar 18, 2008
Isolated nucleic acid molecules which encode peptides that bind to HLA molecules, and uses thereof
LUDWIG INST CANCER RES0 citations51